Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis

• Published in: Health and quality of life outcomes Vol. 11; no. 1; p. 77
• Main Authors: ten Klooster, Peter M, Vonkeman, Harald E, Taal, Erik, Siemons, Liseth, Hendriks, Lidy, de Jong, Alphons J L, Dutmer, Ellen A J, van Riel, Piet L C M, van de Laar, Mart A F J
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.05.2013; BioMed Central
• Subjects: Adult; Arthritis, Rheumatoid - diagnosis; Arthritis, Rheumatoid - psychology; Cohort Studies; Disease; Female; Follow-Up Studies; Health aspects; Health Surveys; Hospitals; Humans; Male; Medical statistics; Middle Aged; Netherlands; Older people; Patient outcomes; Population; Principal Component Analysis; Psychometrics - instrumentation; Quality Indicators, Health Care; Quality of Life; Questionnaires; Registries; Reproducibility of Results; Rheumatic diseases; Rheumatoid arthritis; Rheumatology; Surveys and Questionnaires - standards; Validation studies; Validity; Netherlands
• ISSN: 1477-7525; 1477-7525
• DOI: 10.1186/1477-7525-11-77

The aim of this study was to examine the measurement properties of the Dutch SF-36 version 2 (SF-36v2) health survey in patients with rheumatoid arthritis (RA). Scaling assumptions, internal reliability, and internal construct validity were examined using available data from 1884 RA patients included in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. External construct validity and responsiveness to change were examined using baseline and 6-month follow-up data from a subset of 387 early RA patients participating in the DREAM remission induction cohort. The individual items of the SF-36v2 adequately met scaling assumptions, although four items correlated too highly with items from different scales. Internal consistency was high for all eight scales and the physical and mental health components underlying the scales were replicated, supporting the use of the standard scoring algorithms. The SF-36v2 scales demonstrated minimal floor effects and ceiling effects were noteworthy only for the role-physical, social functioning, and role-emotional scales. Correlations with other core measures were as expected and the SF-36v2 showed excellent known-groups validity in distinguishing between patients with low or moderate-high disease activity. All scales related to physical health showed moderate to large responsiveness to change in patients that achieved low disease activity at six months. The SF-36v2 appears to be a psychometrically sound tool for the assessment of health-related quality of life of Dutch patients with RA.